All Type of News
Should Onglyza, Zemiglo and Nesian be happy or sad on the decision?
The second type diabetes treatments of the DPP-4 inhibitor type,‘Onglyza’(generic name: saxagliptin), ‘Zemiglo’ (generic name: gemigliptin) and‘Nesian’ (generic name: alogliptin), have stuck in a ambiguous situation.
...
Ildong Pharmaceutical stated “Actions of Green Cross can be seen as a hostile M&A”Ildong Pharmaceutical stated about its position in regards of the Green Cross’s shareholders’ right to make proposal.
Ildong Pharmaceutical stated through ‘The Company’s Positi...
|
CrystalGenomics made a contract to sell the new drug, ‘Acelex’, with Daewoong Pharmaceutical
The new drug bio venture, CrystalGenomics, officially announced on 9 February that the company made a contract with Daewoong Pharmaceutical to sell ‘Acelex (nonsteroidal anti-inflammatory drugs)’ that acquired the new...
The annual social damage caused by diseases is worth of KRW 120.653 trillion
It is known that the social damage caused by diseases has reached annually KRW 120.653 trillion in 2012.
The National Health Insurance Service (chairman Sang-cheol Sung) unveiled the study result of the ‘Socioeconomi...
While Celebrex is in trouble, new drugs and generics will all enter the market on June
In order to take an advantage on Celebrex (celecoxib, Pfizer) worth of KRW 60 billion in the anti-inflammatory drug market, domestic pharmaceutical companies are getting ready for the ‘June Air Attack’.
Celebrex, sho...
Will exports of domestic pharmaceutical products keep the momentum as showing a 10% increase?
The exports of domestic pharmaceutical products overcame the weak Yen impact and increased 10% up last year.
According to the Korea Pharmaceutical Traders Association’s (president Jung-gyu Lee) import and export perf...
Among 2nd to 4th generations of pharmaceutical companies, 1 out of 2 are mid 30s and 40s
Pharmaceutical companies have strengthened their ownership.
While 2nd generations are already dominating in the industry, 3rd generations are starting to participate in managements as chairmen, executive directors, v...
The Korea Pharmaceutical Distribution Association declared a war against GSK
While the Korea Pharmaceutical Distribution Association (KPDA) has requested GSK to dismiss the business policy to reduce the number of client companies, it is stated that it will begin a war if the request is not acc...
‘C-Tri’ has first acquired the oral treatment for spinocerebellar degeneration in Korea
The pharmaceutical company specializing in the non-natureamino acid mass production technology and peptide,‘C-Tri’ (CEO Wan-ju Kim), has acquired the domestic approval to manufacture and sell ‘Citrelin ODT 5mg’ on the...
New drugs and generics will enter the arthritis treatment market with a full of medications that reduced the heartburn side effect
It is known that the nonsteroidal anti-inflammatory drug (NSAIDs) market is getting hotter as many arthritis treatments that reduced gastrointestinal side effects enter.
As the Pfizer’s COX-2 inhibitor ‘Celebrex’ is ...
